Cancer Incidence after Initiation of Antimuscarinic Medications for Overactive Bladder in the United Kingdom: Evidence for Protopathic Bias

STUDY OBJECTIVE: To estimate the incidence of 10 common cancers among patients treated with antimuscarinic medications for overactive bladder (AMOABs). DESIGN: Retrospective cohort study. DATA SOURCE: United Kingdom's Clinical Practice Research Datalink. PATIENTS: A total of 119,912 adults with...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Pharmacotherapy
Autori principali: Kaye, James A., Margulis, Andrea V., Fortuny, Joan, McQuay, Lisa J., Plana, Estel, Bartsch, Jennifer L., Bui, Christine L., Perez‐Gutthann, Susana, Arana, Alejandro
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2017
Soggetti:
Original Research Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5518180/
https://ncbi.nlm.nih.gov/pubmed/28370075
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/phar.1932
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi